AAAAAA
Results:
1-17
|
Results: 17
Authors:
Eisenhauer, E
Dancey, J
Citation: E. Eisenhauer et J. Dancey, Impact of new non-cytotoxics in the treatment of ovarian cancer, INT J GYN C, 11, 2001, pp. 68-72
Authors:
Dent, S
Zee, B
Dancey, J
Hanauske, A
Wanders, J
Eisenhauer, E
Citation: S. Dent et al., Application of a new multinomial phase II stopping rule using response andearly progression, J CL ONCOL, 19(3), 2001, pp. 785-791
Authors:
Seymour, L
Eisenhauer, E
Citation: L. Seymour et E. Eisenhauer, A review of dose-limiting events in phase I trials: antimetabolites show unpredictable relationships between dose and toxicity, CANC CHEMOT, 47(1), 2001, pp. 2-10
Authors:
Shepherd, FA
Dancey, J
Arnold, A
Neville, A
Rusthoven, J
Johnson, RD
Fisher, B
Eisenhauer, E
Citation: Fa. Shepherd et al., Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma - A study of the National Cancer Institute of Canada Clinical Trials Group, CANCER, 92(3), 2001, pp. 595-600
Authors:
Miller, WH
Reyno, LM
Loewen, GR
Huan, S
Winquist, E
Moore, M
Cato, A
Jaunakais, D
Truglia, JA
Matthews, S
Dancey, J
Eisenhauer, E
Citation: Wh. Miller et al., A phase I-II study of 9-cis retinoic acid and interferon-alpha 2b in patients with advanced renal-cell carcinoma: An NCIC Clinical Trials Group study, ANN ONCOL, 11(11), 2000, pp. 1387-1389
Authors:
Hoskins, P
Eisenhauer, E
Vergote, I
Dubuc-Lissoir, J
Fisher, B
Grimshaw, R
Oza, A
Plante, M
Stuart, G
Vermorken, J
Citation: P. Hoskins et al., Phase II feasibility study of sequential couplets of cisplatin/topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: A National Cancer Institute of Canada Clinical Trials Group Study, J CL ONCOL, 18(24), 2000, pp. 4038-4044
Authors:
Gelmon, KA
Latreille, J
Tolcher, A
Genier, L
Fisher, B
Forand, D
D'Aloisio, S
Vernillet, L
Daigneault, L
Lebecq, A
Besenval, M
Eisenhauer, E
Citation: Ka. Gelmon et al., Phase I dose-finding study of a new taxane, RPR 109881A, administered as aone-hour intravenous infusion days 1 and 8 to patients with advanced solidtumors, J CL ONCOL, 18(24), 2000, pp. 4098-4108
Authors:
Geels, P
Eisenhauer, E
Bezjak, A
Zee, B
Day, A
Citation: P. Geels et al., Palliative effect of chemotherapy: Objective tumor response is associated with symptom improvement in patients with metastatic breast cancer, J CL ONCOL, 18(12), 2000, pp. 2395-2405
Authors:
Johnston, JB
Eisenhauer, E
Wainman, N
Corbett, WEN
Zaentz, SD
Daeninck, P
Citation: Jb. Johnston et al., Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): A National Cancer Institute of Canada Study, SEMIN ONCOL, 27(2), 2000, pp. 32-36
Authors:
Flinn, IW
Kopecky, KJ
Foucar, MK
Head, D
Bennett, JM
Huchison, R
Corbett, W
Cassileth, P
Habermann, T
Golomb, H
Rai, K
Eisenhauer, E
Appelbaum, F
Cheson, B
Grever, MR
Citation: Iw. Flinn et al., Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin, BLOOD, 96(9), 2000, pp. 2981-2986
Authors:
James, K
Eisenhauer, E
Christian, M
Terenziani, M
Vena, D
Muldal, A
Therasse, P
Citation: K. James et al., Measuring response in solid tumors: Unidimensional versus bidimensional measurement, J NAT CANC, 91(6), 1999, pp. 523-528
Authors:
James, K
Eisenhauer, E
Therasse, P
Citation: K. James et al., Measure once or twice - Does it really matter?, J NAT CANC, 91(20), 1999, pp. 1780-1780
Authors:
Kirkbride, P
Gelmon, K
Eisenhauer, E
Citation: P. Kirkbride et al., Paclitaxel and concurrent radiotherapy in locally advanced non-small cell lung cancer: The Canadian experience, SEM RAD ONC, 9(2), 1999, pp. 102-107
Authors:
Crump, M
Lipton, J
Hedley, D
Sutton, D
Shepherd, F
Minden, M
Stewart, K
Beare, S
Eisenhauer, E
Citation: M. Crump et al., Phase I trial of sequential topotecan followed by etoposide in adults withmyeloid leukemia: a National Cancer Institute of Canada Clinical Trials Group Study, LEUKEMIA, 13(3), 1999, pp. 343-347
Authors:
Rusthoven, JJ
Eisenhauer, E
Butts, C
Gregg, R
Dancey, J
Fisher, B
Citation: Jj. Rusthoven et al., Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study, J CL ONCOL, 17(4), 1999, pp. 1194-1199
Authors:
Khoo, K
Brandes, L
Reyno, L
Arnold, A
Dent, S
Vandenberg, T
Lebwohl, D
Fisher, B
Eisenhauer, E
Citation: K. Khoo et al., Phase II trial of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine. HCl and doxorubicin chemotherapy in metastatic breast cancer: A National Cancer Institute of Canada Clinical Trials Group Study, J CL ONCOL, 17(11), 1999, pp. 3431-3437
Authors:
Gelmon, K
Eisenhauer, E
Bryce, C
Tolcher, A
Mayer, L
Tomlinson, E
Zee, B
Blackstein, M
Tomiak, E
Yau, J
Batist, G
Fisher, B
Iglesias, J
Citation: K. Gelmon et al., Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer, J CL ONCOL, 17(10), 1999, pp. 3038-3047
Risultati:
1-17
|